Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

INMD stock hub

InMode Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

884.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INMD

In the news

Latest news · INMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.2

P25 12.3P50 18.4P75 33.1

Trailing P/E10.3

P25 14.9P50 23.2P75 38.5

ROE13.6

P25 -105.6P50 -46.5P75 -3.1

ROIC51.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

258

Groups with data

Currency

USD

Showing 258 of 258 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001742692
Company name	InMode Ltd.
Country	Israel
Country code	US
Cusip	M5425M103
Employees	660
Employees Change	61%
Employees Change Percent	10.18
Enterprise value	$352.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2019-08-08
Isin	IL0011595993
Last refreshed	2026-05-10
Market cap	$884.5M
Market cap category	Small-Cap
Price	$13.96
Price currency	USD
Rev Per Employee	567,633.33x
Sector	Healthcare
Sic	3845
Symbol	INMD
Website	https://www.inmodemd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.86%
EV Earnings	4.04x
EV Sales Forward	0.94x
EV/EBIT	4.41x
EV/EBITDA	4.37x
EV/FCF	4.12x
EV/Sales	0.94x
FCF yield	9.67%
Forward P/E	10.17x
P/B ratio	1.34x
P/E ratio	10.28x
P/S ratio	2.36x
PE Ratio10 Y	16.25x
PE Ratio3 Y	9.68x
PE Ratio5 Y	14.73x
PS Forward	2.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.31%
EBITDA Margin	21.49%
FCF margin	22.83%
Gross margin	77.84%
Gross Profit	$291.6M
Gross Profit Growth	-7.15%
Gross Profit Growth Q	1.05%
Gross Profit Growth3 Y	-9.81%
Gross Profit Growth5 Y	8.22%
Net Income	$87.2M
Net Income Growth	-50.4%
Net Income Growth Q	-36.48%
Net Income Growth Years	0%
Net Income Growth3 Y	-20.12%
Net Income Growth5 Y	-1.75%
Pretax Margin	27.28%
Profit Margin	23.27%
Profit Per Employee	$132,109
Profitable Years	9
ROA	6.86
Roa5y	16.14
ROCE	11.85
ROE	13.62
Roe5y	29.96
ROIC	51.39
Roic5y	11,817.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.83%
Cagr3y	-25.44%
Cagr5y	-18.38%
EPS Growth	-40.75
EPS Growth Q	-30.77
EPS Growth Years	0
EPS Growth3 Y	-12.1
EPS Growth5 Y	3.78
FCF Growth	-29.86%
FCF Growth Q	8.99%
FCF Growth3 Y	-20.34%
FCF Growth5 Y	-2.55%
OCF Growth	-29.36%
OCF Growth Q	9.56%
OCF Growth3 Y	-20.27%
OCF Growth5 Y	-2.42%
Revenue Growth	-4.53x
Revenue Growth Q	5.32x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.57x
Revenue Growth5 Y	10.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.51
Assets	$750.8M
Cash	$537.2M
Current Assets	$680.8M
Current Liabilities	$77.4M
Debt	$4.8M
Debt EBITDA	$0.06
Debt Equity	$0.01
Debt FCF	$0.06
Equity	$661.3M
Liabilities	$89.6M
Long Term Assets	$70.1M
Long Term Liabilities	$12.2M
Net Cash	$532.3M
Net Cash By Market Cap	$60.19
Net Cash Growth	4.93%
Net Debt EBITDA	$-6.61
Net Debt Equity	$-0.81
Net Debt FCF	$-6.22
Tangible Book Value	$661.3M
Tangible Book Value Per Share	$10.43
WACC	15.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.8
Inventory Turnover	1.23
Net Working Capital	$66.3M
Quick ratio	7.47
Working Capital	$603.4M
Working Capital Turnover	$0.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	16.21%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.83%
200-day SMA	14.47
3Y total return	-58.56%
50-day SMA	13.83
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.77%
All Time High	99.27
All Time High Change	-85.94%
All Time High Date	2021-11-02
All Time Low	6.53
All Time Low Change	113.78%
All Time Low Date	2019-08-08
ATR	0.38
Beta	1.97
Beta1y	0.88
Beta2y	0.96
Ch YTD	-4.97
High	14.15
High52	16.74
High52 Date	2025-10-09
High52ch	-16.61%
Low	13.85
Low52	12.72
Low52 Date	2026-03-12
Low52ch	9.75%
Ma50ch	0.94%
Premarket Change Percent	0.93
Premarket Price	$14.05
Premarket Volume	595
Price vs 200-day SMA	-3.5%
RSI	47.37
RSI Monthly	40.59
RSI Weekly	46.91
Sharpe ratio	-0x
Sortino ratio	0.17
Total Return	16.21%
Tr YTD	-4.97
Tr1m	2.27%
Tr1w	-3.12%
Tr3m	-7.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$14.5
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.33
Earnings EPS Estimate Growth	6.45
Earnings Revenue Estimate	79,857,200x
Earnings Revenue Estimate Growth	2.55x
Operating Income	$79.8M
Operating Income Growth	-27.47
Operating Income Growth Q	-35.61
Operating Income Growth3 Y	-26.84
Operating Income Growth5 Y	-3.14
Operating margin	21.31
Price target	$16
Price Target Change	$14.61
Price Target Change Top	$3.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,931,977%
Float Percent	86.7%
Shares Insiders	11.97%
Shares Institutions	51.79%
Shares Out	63,358,750
Shares Qo Q	-0.22%
Shares Yo Y	-16.21%
Short Float	5.92%
Short Ratio	3.32
Short Shares	5.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$74.2M
Average Volume	717,011.85x
Bv Per Share	10.43
CAPEX	$-1.1M
Ch1m	2.27
Ch1w	-3.12
Ch1y	-1.83
Ch3m	-7.43
Ch3y	-58.56
Ch5y	-63.77
Ch6m	-3.39
Change	0.29%
Change From Open	-0.14
Close	13.92
Days Gap	0.43
Depreciation Amortization	696,000
Dollar Volume	19,327,243.1
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$79.8M
EBITDA	$80.5M
EPS	$1.36
F Score	5
FCF	$85.5M
FCF EV Yield	24.29x
FCF Per Share	$1.35
Financing CF	-59,019,000
Fiscal Year End	December
Founded	2,008
Graham Number	17.85501
Graham Upside	27.9
Income Tax	$15M
Investing CF	219,650,000
Ipr	-0.29
Iprfo	106.8
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2021-10-01
Last Split Type	Forward
Last10k Filing Date	2026-02-10
Lynch Fair Value	$6.79
Lynch Upside	-51.34
Ma150	14.41
Ma150ch	-3.14%
Ma20	14.26
Ma20ch	-2.08%
Net CF	248,347,000
Next Earnings Date	2026-07-29
Open	13.98
Optionable	Yes
P FCF Ratio	10.34
P OCF Ratio	10.21
Position In Range	36.67
Post Close	13.96
Postmarket Change Percent	0.5
Postmarket Price	$14.03
Ppne	11,226,000
Pre Close	13.92
Price Date	2026-05-08
Price EBITDA	$10.98
Ptbv Ratio	1.34
Relative Volume	1.93x
Revenue	374,638,000x
SBC By Revenue	3.02x
Share Based Comp	11,312,000
Tax By Revenue	4.01x
Tax Rate	14.69%
Tr6m	-3.39%
Volume	1,384,473

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INMD pay a dividend?

Capital-return profile for this ticker.

Performance

INMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+51.8%

Float: +86.7% of shares outstanding

Insider ownership

+12.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.4

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

1.97

More volatile than the market

Sharpe ratio

-0.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INMD stock rating?

InMode Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INMD analysis?

The full report lives at /stocks/INMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INMD?

The latest report frames INMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.